CVS Caremark to purchase Coram infusion business from Apria Healthcare, expanding specialty pharmacy offering
MLex Summary: NYSE-listed drug retailing company CVS Caremark has agreed to acquire privately-held Apria Healthcare Group's specialty infusion services and enteral nutrition business unit Coram for $2.1 billion. The deal is expected to close by the end of...To view the full article, register now.
Already a subscriber? Click here to view full article